Guardant Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Guardant Health, Inc. on February 23, 2022. The filing serves to announce the Company's financial results for the fiscal quarter and full year ended December 31, 2021. The detailed results are contained in a press release furnished as Exhibit 99.1.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being included in the press release (Exhibit 99.1) but are not explicitly stated in the body of this 8-K document.
Material Changes
No specific material changes versus prior periods are detailed in the text of this filing. The document solely references the issuance of the press release containing the comparative financial data.
Guidance, Outlook, and Risks
The filing does not provide specific guidance, outlook, management commentary, or risk factors within its text. It notes that the information furnished, including the press release, is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings except as expressly set forth.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated February 23, 2022) for specific revenue, net loss, and cash flow figures for Q4 and FY 2021.
- Verify the Company's liquidity position and cash burn rate as detailed in the referenced press release.
- Confirm any updated full-year 2022 guidance provided in the press release.
- Check for any new material risks or contingencies disclosed in the full press release text.